What a test can show
Clinical TTR sequencing with confirmation and target-organ assessment.
Monogenic conditions
TTRHereditary transthyretin amyloidosis
Pathogenic variants can cause amyloid polyneuropathy and/or cardiomyopathy.
RELATIONSHIP VALIDITYHigh: established causality
ACTIONABILITYHigh after phenotype confirmation
SOURCE CHECKLinks and claim boundaries are editorially checked; external expert review is stated only with named disclosure
Practical meaning
Early, accurate diagnosis can be clinically meaningful.
Where knowledge ends
Onset and organ involvement vary; carrier status is not the same as current disease.
SOURCES AND VERSION
Verifiable, not ‘trust us’.
Updated: 14 August 2026. Any clinical interpretation requires the exact variant, testing method, family information and medical context.